Intratumoral heterogeneity of microRNA expression in breast cancer.
Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, Höfler H, Avril S
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of tumor heterogeneity and section number and thickness on miRNA levels and the effects of tumor heterogeneity on ki-67 IHC in FFPE breast tumors and lymph node metastases. All primary breast tumors were >3 cm and contained >70% tumor. 2-3 samples, at least 5 mm apart from the periphery (within 5 mm of the edge), center (within 10 mm of center) and intermediate zones (between periphery and central), were taken, and RNA was extracted after proteinase K digestion using FFPE miRNeasy. When available (8 of 16 patients), RNA was also obtained from lymph node metastases.
Summary of Findings
The number of sections, section thickness, and amount of extraction buffer used did not affect miRNA expression profiles. Further, a high degree of reproducibility in miRNA expression was found between repeat extractions from the same and replicate samples. The small nucleolar RNA U48 showed low intratumoral and intertumoral variation, but the small nucleolar RNA U44, and the miRNAs miR-16 and let-7a showed higher intratumoral heterogeneity (p=0.005). The intratumoral heterogeneity was 30% for miR-10b, 33% for miR-210, 44% for miR-335, and 51% for miR-31. Within zone heterogeneity and between zone heterogeneity led to similar variability in expression of all 4 miRNAs, but for miR-31, miR-10b, and miR-210, the intermediate zone showed less heterogeneity than the center and periphery. The authors report that tumor diameter, tumor cell content, or using primary tumor versus metastasis had no effects on the expression variability of miRNA levels, but miRNA expression differed greatly between the patients. Ki-67 immunostaining showed a coefficient of variance (CV) of 28% in primary tumors and 17% in lymph node metastases, and CVs of 5% in the intermediate zone, 22% in the center, and 23% in the periphery. Ki-67 expression was highly variable between patients (CV of 63-112%).
Biospecimens
TissueLymph NodeTissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
RNAReal-time qRT-PCRProteinImmunohistochemistryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location BreastLymph node metastasisBiospecimen Aliquots and Components Aliquot size/volume 10 um section2 sections4 sections5 um sectionBiospecimen Aliquots and Components Biospecimen heterogeneity Between core and peripheryBiospecimen coreBiospecimen peripheryAnalyte Extraction and Purification Analyte isolation method 150 uL extraction buffer240 uL extraction bufferReal-time qRT-PCR Specific Targeted nucleic acid RNU33RNU48let-7amiR-10bmiR-16miR-210miR-31miR-335Immunohistochemistry Specific Targeted peptide/protein Ki-67